Israelis from a lower socioeconomic background are more likely to be obese and less likely to undergo cancer screening, according to the 2025 report by the National Program for Quality Indicators in Community Healthcare, published Tuesday.
The report also highlights persistent disparities in access to a range of health services between central Israel and the periphery, as well as between Jewish and Arab communities.
The link between economic status and obesity is particularly pronounced among women. Obesity rates among women in the lowest socioeconomic bracket stood at 36.8 percent, compared with 19.1 percent among those in the highest bracket.
The gap was also evident among men, though less pronounced: 27.3 percent of men in the lowest bracket were obese, compared with 19 percent in the highest.
Significant disparities were also found between the general population and Arab society. Obesity rates among Arab women reached 35 percent in the 20-64 age group and 53 percent among women aged 65-84.
The report, which analyzed the data by socioeconomic status using Central Bureau of Statistics figures and additional analyses, found that more than 62 percent of Israeli men and approximately 57 percent of women aged 20-64 are either overweight or obese.
Israel’s failing schools leave no student unscathed Lior Dattel
Among older adults aged 65-84, however, obesity rates have been declining. The report’s authors attribute this trend, in part, to the growing use of GLP-1 medications, such as Ozempic, which have entered the Israeli market in recent years.
By contrast, obesity rates among seven-year-old children have been rising slowly but steadily. In 2025, the rate reached 8.6 percent, the highest since monitoring began in 2014, when it stood at 7.9 percent.
Cancer screening is another area in which the report found significant disparities. In the ultra-Orthodox community, only 53 percent of men aged 50-74 underwent screening for colorectal cancer, compared with 64.4 percent of men in the same age group in the general population and 62.5 percent in Arab society.
Significant gaps were also found among women. Among those in the highest socioeconomic bracket, 76.1 percent underwent mammograms for the early detection of breast cancer, compared with 66.8 percent of women in the lowest bracket. The disparity was even more pronounced in cervical cancer screening: 80.3 percent of women in the highest bracket underwent screening, compared with just 49.7 percent in the lowest.
In the field of mental health, the use of antidepressants continues to rise across the population, alongside a sharp increase in the use of anti-anxiety medication in Arab society.
In 2025, there were 703 purchases of antidepressants per 1,000 people, an increase of approximately 14 percent since 2022 and 2.6 percent compared with 2024. Arab society recorded the steepest increase in antidepressant use, at 29 percent.
The National Program for Quality Indicators in Community Healthcare, led by the Israel National Institute for Health Policy Research, has been monitoring public health indicators across a range of fields since 2014.
The program’s head, Prof. Ronit Calderon-Margalit of the School of Public Health at Hadassah Medical Center and the Hebrew University of Jerusalem, noted that the report also highlights encouraging trends in the public’s health habits.
Speaking to Haaretz, Calderon-Margalit welcomed the steady increase in the number of women undergoing screening for the early detection of cervical cancer.
“We’re seeing an increase in screening across all segments of the population, accompanied by a decline in mortality. There are still disparities, but this is a significant improvement,” she said.
According to Calderon-Margalit, the positive trend is not attributable to the HPV vaccine, since the women and girls who have been vaccinated are still too young to affect the overall figures.
Early detection and vaccination against cervical cancer, she said, “make it possible to defeat the disease,” adding that “there’s no reason for it to exist.”
The figures on colorectal cancer screening, by contrast, are less encouraging. Calderon-Margalit said that after a substantial increase in screening rates in recent years, progress has stalled.
“We’re seeing stagnation both in early detection screening and in colonoscopies among people whose initial tests revealed suspicious findings,” she said.
When efforts to promote screening began in 2003, only about 12 percent of the target population underwent testing. Today, the rate stands at 65 percent.
“There has been tremendous progress over the years, which was also reflected in a decline in mortality, but at the moment we’re stuck,” she said.
It is unclear why colorectal cancer screening rates have been unable to rise beyond their current level. Possible explanations include the unpleasant nature of the procedure or insufficient encouragement from physicians for patients to undergo testing.
Calderon-Margalit acknowledged that colonoscopies are uncomfortable and require preparation. However, she stressed that they are particularly effective, as they not only help detect cancer early but also allow doctors to remove suspicious growths found during the procedure. This, she said, is precisely why promoting screening is so important.

